ID   MyLa 2039
AC   CVCL_5341
SY   MyLa2039; My-La 2039
DR   BTO; BTO_0004842
DR   Wikidata; Q54907184
RX   PubMed=17179233;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3467; Primary cutaneous T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171901; Primary cutaneous T-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5340 ! MyLa 1929
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
RX   PubMed=17179233; DOI=10.1182/blood-2006-04-017863; PMCID=PMC1852254;
RA   Woetmann A., Lovato P., Eriksen K.W., Krejsgaard T.F., Labuda T.,
RA   Zhang Q., Mathiesen A.-M., Geisler C., Svejgaard A., Wasik M.A.,
RA   Odum N.;
RT   "Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the
RT   presence of bacterial toxins.";
RL   Blood 109:3325-3332(2007).
//